Zocca Mai-Britt 4
4 · IO Biotech, Inc. · Filed Apr 4, 2025
Insider Transaction Report
Form 4
IO Biotech, Inc.IOBT
Zocca Mai-Britt
DirectorChief Executive Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-04-02+580,000→ 580,000 totalExercise: $1.07Exp: 2035-04-02→ Common Stock (580,000 underlying)
Footnotes (1)
- [F1]One-fourth of these options vest on April 2, 2026, and 1/36th of the remaining options vest each month thereafter, subject to the reporting person's continued service through the applicable vesting date, and subject to 25% acceleration upon termination of service by the issuer without cause and 100% acceleration upon termination of service by the Issuer without cause if such termination occurs within 24 months of a change of control.